Antiviral Therapy

Antiviral Therapy is a medical journal on the development of drugs against viruses, published by SAGE for the International Society for Antiviral Research.《Antiviral Therapy》是一份聚焦抗病毒药物研发的医学期刊，由 SAGE 为国际抗病毒研究学会出版。

It was founded in 1996 and carries primary papers and reviews on the clinical development of antiviral drugs.该刊创办于 1996 年，载有关于抗病毒药物临床开发的原始论文与综述。

In the 2025 edition of the journal citation report it holds an impact factor of 3.3, and it stands in the second quartile of infectious diseases.在 2025 年版期刊引证报告中，该刊的影响因子为 3.3，在传染病学类目列第二区。

Scope

• The journal takes the clinical development of antiviral drugs as its subject, and it asks how a compound is carried toward a patient.该刊以抗病毒药物的临床开发为题材，追问化合物如何被带向患者。

• Virology is named, and the journal carries work on how a virus replicates and how a drug interrupts it.病毒学被点名，该刊刊载病毒如何复制、药物如何打断它的工作。

• Infectious diseases are treated, and the journal admits work on how an infection is managed in a person.传染病学得到处理，该刊收载感染如何在患者身上被管理的工作。

• HIV research is a central subject, and the journal carries work on how the virus is suppressed over the long term.HIV 研究是核心选题，该刊刊载病毒如何被长期抑制的工作。

• Hepatitis viruses are named among the subjects, and the journal takes work on how a chronic infection is treated.肝炎病毒列于选题之中，该刊收载慢性感染如何被治疗的工作。

• Influenza and herpesviruses are treated, and the journal admits work on drugs that act against them.流感与疱疹病毒得到处理，该刊收载针对它们的药物方面的工作。

• Emerging viral pathogens are named, and the journal carries work on a disease that has newly appeared.新发病毒病原被点名，该刊刊载新近出现疾病的工作。

• Clinical pharmacology is part of the remit, and the journal takes work on how a drug is dosed and how it behaves in the body.临床药理学属于收稿范围，该刊收载药物如何给药、在体内如何表现的工作。

• Resistance is treated, and the journal carries work on how a virus escapes a drug and how the escape is met.耐药得到处理，该刊刊载病毒如何逃逸药物、逃逸如何被应对的工作。

• Antiviral mechanisms of action are named, and the journal admits work on how a compound works at the molecular level.抗病毒作用机制被点名，该刊收载化合物在分子层面如何起作用的工作。

• Clinical trials are treated, and the journal takes work on how a regimen is tested against a comparison.临床试验得到处理，该刊收载方案如何对照参比受检验的工作。

• Treatment strategy is named, and the journal carries work on how a regimen is chosen and combined.治疗策略被点名，该刊刊载方案如何被选择与组合的工作。

• Primary papers are the main offering, and the journal publishes reviews alongside them.原始论文是主要内容，该刊并载综述。

• The journal is meant to serve clinicians and pharmacologists, and it takes work from the laboratory as well as from the ward.该刊意在服务临床医生与药理学家，实验室与病房的工作兼收。

History

• The journal was founded in 1996, and it has carried work on antiviral treatment from its first volume.该刊创办于 1996 年，自首卷起便载有抗病毒治疗方面的工作。

• It was issued for many years from a medical press in London, and the list later passed to a larger publisher.该刊多年由伦敦的一家医学出版社发行，刊物名录后来转入一家更大的出版方。

• A society for antiviral research stands behind the title, and its field is recorded in these pages.一个抗病毒研究学会为该刊提供支撑，该刊作为其领域的记录。

• The pair of numbers has stayed with the title, and the print and electronic editions share the same strings of digits.该对刊号一直伴随题名，印本与电子版共用同样的数字串。

• The journal was issued eight times a year for a stretch, and it now appears six times a year in a two month rhythm.该刊曾有一段时期每年八期，如今以两月节奏每年出六期。

• A volume is published for each year, and the series had reached volume 31 by 2026.该刊每年出版一卷，到 2026 年已出至第 31 卷。

• Articles are published online ahead of an issue, so that a paper may appear before the issue it is assigned to.论文先于某一期在线发表，因而一篇论文可以在其所归的某一期之前出现。

• Access became open in recent years, and every article is now free to read from the moment it appears.该刊近年转为开放获取，每篇文章如今自出现那一刻起即可免费阅读。

• The impact figure has risen in recent editions, standing at 1.3 for 2023 and reaching 3.3 in the 2025 edition.影响因子在近期各版中上升，2023 年为 1.3，2025 年版为 3.3。

• The journal is indexed in the science citation index expanded, and it is carried in MEDLINE and in PubMed.该刊被科学引文索引扩展版收录，并被 MEDLINE 与 PubMed 收录。

• It is also listed in the index medicus and in the usual pharmacological and virological abstracting services.该刊亦被医学索引以及惯常的药理学与病毒学文摘服务收录。

• Supplements have been issued alongside the journal, and it has gathered papers on a single drug or a single virus.该刊曾随正刊出版增刊，汇集关于某一药物或某一病毒的论文。

Editors

• Douglas D. Richman of the University of California, San Diego is editor-in-chief, and his own field is the treatment of viral infection.加州大学圣迭戈分校的（Douglas D. Richman）担任主编，其本人领域为病毒感染的治疗。

• The journal is edited by section, and each branch of the field has its own section editor.该刊按栏目编辑，领域的每一分支各有自己的栏目编辑。

• Those section editors cover clinical HIV, hepatitis viruses, herpesviruses, and emerging and other viruses.这些栏目编辑覆盖临床 HIV、肝炎病毒、疱疹病毒，以及新发与其他病毒。

• The section editors are drawn from universities in the United States, the Netherlands, Britain and France.这些栏目编辑来自美国、荷兰、英国与法国的大学。

• The journal sets out the classes of manuscript it takes, along with the length and structure each of them should follow.该刊列明所收稿件的类别，以及各类别应遵循的篇幅与结构。

• Each paper is sent to independent referees, and the review is anonymous on the side of the reviewer.每篇论文送交独立审稿人，评审在审稿人一侧为匿名。

• Authors must declare any competing interest, and the journal states its ethical requirements in full.作者必须声明任何利益冲突，该刊完整说明其伦理要求。

• Work that involves patients is held to the usual standards, and the journal asks that consent and approval be recorded.涉及患者的研究须达到惯常标准，该刊要求记录知情同意与批准情况。

• Clinical trials are asked to give their registration, and a statement on data sharing is required.临床试验须给出注册信息，并须提交数据共享声明。

• Manuscripts are submitted through the publisher's system, and the editorial office may be contacted before submission.稿件通过出版方的系统投递，编辑部可在投稿前联系。

• The journal is read by clinicians and by pharmacologists, by virologists and by trialists, and it writes for all of them.该刊的读者既有临床医生与药理学家，也有病毒学家与试验研究者，它为这几类人写作。

• Work that carries a laboratory compound toward a trial is given room, and the journal asks what the carrying changes.把实验室化合物带向试验的工作有篇幅可用，该刊追问这一带动改变了什么。

• Studies that report a negative result are taken, since a regimen that failed to suppress a virus is worth recording.报告阴性结果的研究也在收载之列，因为未能抑制病毒的方案同样值得记录。

• Work on viral load appears among the subjects, and the journal carries papers on how the amount of virus tracks the course of a disease.病毒载量方面的工作列于选题之中，该刊刊载病毒量如何追踪病程的论文。

• Work on a genotypic resistance test is treated, and the journal admits papers on how a mutation predicts a drug's fate.基因型耐药检测方面的工作得到处理，该刊收载变异如何预示药物成败的论文。

• The journal keeps its reviews distinct from its primary papers, and a reader can tell from the rubric which is which.该刊把综述与原始论文区分开来，读者可从栏目看出何者为何者。

• Work on a drug combination is named, and the journal carries papers on how two agents are given together to hold a virus down.药物组合方面的工作被点名，该刊刊载两种药剂如何合用压住病毒的论文。

• Work on adherence is treated, and the journal asks why a patient might stop a regimen that is working.依从性方面的工作得到处理，该刊追问患者为何可能中断一个奏效的方案。

• Work on the safety of a long course of treatment is named, and the journal carries papers on the harm that accumulates.长期疗程的安全性方面的工作被点名，该刊刊载累积损害方面的工作。

• Work on an emerging pathogen is treated, and the journal admits papers on how a drug is found quickly for a new disease.新发病原方面的工作得到处理，该刊收载针对新疾病如何被迅速找到药物的论文。

• The journal follows the publisher's policy on research integrity, and it records corrections and withdrawals where they arise.该刊遵循出版方的研究诚信政策，出现更正与撤稿时予以记录。